The TrumpRx site now lists more than 61 discounted medications from 11 drugmakers, up from about 40 when it launched in February.

Moderate to severe glabellar lines may be effectively and safely treated with YY001, a new recombinant botulinum toxin type A product.

Despite the initiation of a phase 3 confirmatory trial, the FDA remains unsatisfied with the interpretability of phase 2 data for Replimune’s oncolytic immunotherapy.

Circulating tumor HPV DNA levels were linked to clinical risk in patients having surgery for HPV-related oropharyngeal cancer.

Immunocompetent adults younger than 50 years of age experience a substantial HZ burden, with incidence rates comparable to older age groups.

The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.

A new AARP report found 59 million Americans served as unpaid caregivers, working nearly 50 billion hours, valued at $1 trillion, per year.

Childhood cancer was the eighth leading cause of childhood death globally in 2023, though regional disparities emerged.

The global maternal mortality ratio was 190.5 maternal deaths per 100,000 livebirths in 2023, with distinct regional trends.

Dr Jay Bhattacharya delayed the release of a CDC report on COVID-19 vaccine effectiveness due to reported methodology issues.

Hispanic and Black girls with PCOS-related acne receive less prescriptions for acne treatment when compared with White girls.

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...